[HTML][HTML] IFNs Modify the Proteome of Legionella-Containing Vacuoles and Restrict Infection Via IRG1-Derived Itaconic Acid

J Naujoks, C Tabeling, BD Dill, C Hoffmann… - PLoS …, 2016 - journals.plos.org
J Naujoks, C Tabeling, BD Dill, C Hoffmann, AS Brown, M Kunze, S Kempa, A Peter…
PLoS pathogens, 2016journals.plos.org
Macrophages can be niches for bacterial pathogens or antibacterial effector cells depending
on the pathogen and signals from the immune system. Here we show that type I and II IFNs
are master regulators of gene expression during Legionella pneumophila infection, and
activators of an alveolar macrophage-intrinsic immune response that restricts bacterial
growth during pneumonia. Quantitative mass spectrometry revealed that both IFNs
substantially modify Legionella-containing vacuoles, and comparative analyses reveal …
Macrophages can be niches for bacterial pathogens or antibacterial effector cells depending on the pathogen and signals from the immune system. Here we show that type I and II IFNs are master regulators of gene expression during Legionella pneumophila infection, and activators of an alveolar macrophage-intrinsic immune response that restricts bacterial growth during pneumonia. Quantitative mass spectrometry revealed that both IFNs substantially modify Legionella-containing vacuoles, and comparative analyses reveal distinct subsets of transcriptionally and spatially IFN-regulated proteins. Immune-responsive gene (IRG)1 is induced by IFNs in mitochondria that closely associate with Legionella-containing vacuoles, and mediates production of itaconic acid. This metabolite is bactericidal against intravacuolar L. pneumophila as well as extracellular multidrug-resistant Gram-positive and -negative bacteria. Our study explores the overall role IFNs play in inducing substantial remodeling of bacterial vacuoles and in stimulating production of IRG1-derived itaconic acid which targets intravacuolar pathogens. IRG1 or its product itaconic acid might be therapeutically targetable to fight intracellular and drug-resistant bacteria.
PLOS